Navigation Links
12 Month TRAM Data Collated Using TIGR® Matrix Surgical Mesh in a Randomized Controlled Study Presented at MAPACS 2012
Date:3/28/2012

SINGAPORE, March 28, 2012 /PRNewswire/ -- Novus Scientific, manufacturer of TIGR® Matrix Surgical Mesh, the world's first long-term resorbable (100% absorbable) synthetic mesh, proudly announces the presentation of 12 month TRAM flap data gathered by the Division of Plastic Reconstructive and Aesthetic Surgery at NUH Singapore.

The pedicled transverse rectus abdominis myocutaneous (TRAM) flap is a workhorse of autologous breast reconstruction. The main drawback most surgeons have with this option is in the donor site morbidity. Very often, the rectus sheath cannot be closed primarily and the defect has to be bridged using a mesh. Even if the rectus sheath can be apposed, the patient is at risk of having an abdominal hernia from weakness of the abdominal wall. The ideal situation, elaborates Dr Ong, would be to use a non-permanent on-lay graft over the primary repair to strengthen the sheath repair. The graft would give additional strength until fibrosis has set in to provide the additional strength to the repair, and then the mesh would resorb, to minimize the problems associated with the use of a permanent mesh.

"We assessed the early results with the use of a synthetic resorbable mesh as an on-lay graft over our rectus sheath repair in patients who had undergone pedicled TRAM flap for breast reconstruction. All patients were randomized into either using this synthetic resorbable mesh (TIGR® Matrix Surgical Mesh) or a synthetic permanent mesh. Data was collected prospectively, as well as on follow up. Our results showed that there was no significant difference in complication rates between the two groups, up to a follow up of 1 year. There was no difference in patient recovery, hospitalization stay, and pain scores," said Dr. Ong Wei Chen, Consultant Plastic Surgeon,  Division of Plastic, Reconstructive and Aesthetic Surgery - National University Hospital, Singapore.

"This randomized controlled study has shown not only that TIGR® Matrix may well be a suitable resorbable on-lay mesh for use in repair of the rectus sheath after TRAM flap surgery, but it also supports the belief increasingly articulated by general and plastic surgeons around the world, that the world's first long-term resorbable synthetic mesh has opened up a new approach to treating a range of defects requiring reinforcement of soft tissue where weakness exists," said Tac-Whei Ong, VP Global Sales & Marketing, Novus Scientific.

"These results are indeed promising as TIGR® Matrix Surgical Mesh shows potential as a viable treatment option for surgeons weighing the risks of permanent mesh in certain clinical applications," said A/Professor Lim Thiam Chye, Division Head/Senior Consultant, Division of Plastic, Reconstructive and Aesthetic Surgery - National University Hospital, Singapore.

We look forward to sharing the results of the study in a Symposium given by Dr Ong Wei Chen at CHA level 2, The Traders Hotel, Penang Malaysia at 5.15pm on Saturday the 31st of March. For full information of the event in general, please select the MAPACS event here: http://novusscientific.com/events/.

TIGR® Matrix Surgical Mesh is available for sale in the U.S. and selected countries in Europe and Asia.

About Novus Scientific
Novus Scientific (www.novusscientific.com) is an innovator in the development and commercialization of resorbable synthetic medical devices.

Visit our SURGEONS CASES (rest of world) page to see cases relevant to this release:
http://novusscientific.com/tigr-matrix/tigr-matrix-row/surgeons-cases/

Click the following link to see more details about Dr Ong Wei Chen and her lecture: http://novusscientific.com/media/2012/03/MAPACS-wOL.pdf

Visit our PRESSROOMhttp://www.mynewsdesk.com/pressroom/novus-scientific or follow us on Twitter: NovusScientific

TIGR is a registered trademark of Novus Scientific Pte. Ltd   

CONTACT:  Tac-Whei Ong: +66-817 33 9524- tacwhei.ong@novusscientific.com  


'/>"/>
SOURCE Novus Scientific
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. March is Endometriosis Awareness Month
2. HASCO Medical Announces its Fourth Acquisition in the Last 9 Months With the Purchase of Ride-Away
3. NMEDA Introduces National Mobility Awareness Month for Seniors, Veterans and People with Disabilities
4. Drugs & Bugs: A New App from Monthly Prescribing Reference
5. Hospira Works With FDA to Help Avert Methotrexate Shortage; Shipping One Months Supply of New Product Immediately and on Track to Ensure Sustainable Supply
6. Mercy Jets Celebrates Heart Month With Charitable Donations
7. Misonix Reports a 29% and 24% Increase in Revenue for the Second Quarter and Six Months Fiscal 2012 Financial Results
8. 69-Time Gold Medalist and Multi-Sport Wheelchair Athlete Named Spokesperson for National Mobility Awareness Month
9. Pro-Dex, Inc. Announces Fiscal Second Quarter and Six Month Results
10. In Honor of American Heart Month, Joy Behar & Daughter Eve Call on Women to Take the ProHeart Pledge on Facebook
11. ResMed Inc. Announces Record Financial Results For The Quarter Ended And Six Months Ended December 31, 2011
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2017)... 2017 AVACEN Medical (AVACEN) announced that its ... helping those with the widespread pain associated with fibromyalgia ... in Essex, England commented, "I ... experiencing no sleep at all, tremendous pain, with every ... recommend [the AVACEN 100] enough, how this has and ...
(Date:9/18/2017)... , Sept. 18, 2017 ... fields of bioinformatics and immune engineering, today ... protective avian influenza A (H7N9) vaccine. ... related to seasonal influenza and presents a ... on prior exposure to be effective. Using ...
(Date:9/12/2017)... Sept. 12, 2017  ValGenesis Inc., the global ... is pleased to announce the appointment of Dr. ... its Board of Directors and Chairman of Advisory ... life science companies to manage their entire validation ... paper in this process. Furthermore, ValGenesis VLMS enables ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... 13, 2017 , ... The American Board of Family Medicine's (ABFM) Board of ... Executive Officer, succeeding Dr. James C. Puffer upon his retirement. Dr. Newton will serve ... Puffer’s retirement at the end of 2018. Upon assuming the role of President and ...
(Date:10/13/2017)... ... October 13, 2017 , ... ... Pharmacy (SOP) alumni Hannah Randall, PharmD ‘17, and Jennifer Huggins, PharmD ’17, ... guideline updates for the primary prevention of cardiovascular diseases during the 15th ...
(Date:10/13/2017)... ... October 13, 2017 , ... Many families have long-term ... long-term care insurance companies have a waiver for care if the client has a ... when the family pays for care, is often waived, so the benefits from their ...
(Date:10/13/2017)... ... 2017 , ... Global Healthcare Management’s 4th Annual Kids Fun Run brought out ... free event, sponsored by Global Healthcare Management’s CEO, Jon Letko, is aimed at getting ... children of all ages; it is a non-competitive, non-timed event, which is all about ...
(Date:10/13/2017)... ... October 13, 2017 , ... ... Agile Software Development, has been awarded a contract by the Center for Medicare ... (BPA) aims to accelerate the enterprise use of Agile methodologies in a consistent ...
Breaking Medicine News(10 mins):